Displaying items by tag: comprehensive diabetes center

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes.
UAB nutrition researchers are conducting a new study on Type 2 diabetes and addressing the disproportionate complications experienced by African American patients.
A new study from UAB describes the impact of a peer coach intervention on hospitalizations and emergency room visits for individuals with diabetes and depression.
Some 652 participants across four states will be recruited to test the effects of exercise and diet interventions in underserved cancer survivors.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
Recruitment for the trial continues as Myers discusses the benefits she received from participating and the knowledge she has gained to take control of her health care.
Lead author of paper published in Diabetes Research and Clinical Practice journal says, while causal relationship cannot be inferred, findings are “absolutely encouraging.”
Best of 2015 2Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
Three-year grant establishes consortium to better organize and support collaborative research related to the loss of functional beta cell mass in type 1 diabetes.
Page 1 of 2